What's new

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Mar 14, 2025 - 09:39
 0
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Statement Oliver Zipse, Chairman of the Board of Management of BMW AG, Annual Co...

Next Article

Postpone Interfacial Impoverishment of Zn‐Ions via Neodymium‐Based Conversion Fi...

Related Posts

EMEA-003301-PIP01-22-M01

EMEA-003301-PIP01-22-M01

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Bemrist Breezhaler, indacaterol,mometasone, Date of authorisation: 30/05/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 6, 2025  0